ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Biotech ETFs in Focus"
Episode Synopsis
Brad Loncar, Head of Loncar Investments, joins us in studio to spotlight the index behind the Loncar Cancer Immunotherapy ETF (CNCR) and discuss the innovation occurring in cancer treatment. Nate and Conor also explain why ETFs can be an excellent way to access the biotech space in general.
More episodes of the podcast ETF Prime
Top Market & ETF Stories to Watch in 2026
23/12/2025
Horizon Enters, Fidelity Enhances
09/12/2025
ETF Milestones, Top Stories, & What’s Ahead
11/11/2025
An ETF Tour with Bloomberg’s Eric Balchunas
04/11/2025
In God we trust